Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue properties
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 817.00 |
Description | Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue properties |
In vivo | Galnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury[1]. Galnon, a GAL receptor agonist, may enhance osteoclastic bone resorption in OVX rats. Although galnon reduced bone volume, biomechanical testing revealed that bone of galnon-treated animals was mechanically superior per unit area. Taken together, galnon simultaneously improves the intrinsic quality of cortical bone whilst stimulating osteoclastic activity in the OVX rat model[2]. |
Molecular Weight | 678.82 |
Formula | C40H46N4O6 |
CAS No. | 475115-35-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GALNON 475115-35-6 GPCR/G Protein Neuroscience Neuropeptide Y Receptor GAL2 galanin anticonvulsant NPY receptor inhibit anxiolytic Inhibitor GAL1 inhibitor